IPO Listed
BlossomHill Therapeutics IPO
US$150m raised
Lodged Aug 2026 · NASDAQ: BLSM · US$16.00 cash per share
Advisers
Lead managers
- Underwriter
- Legal adviser
- Issuer
- BlossomHill Therapeutics
- Issuer based in
- United States
- Listed
- 7 Aug 2026
- Sector
- Biotech
- Tags
- Biotech, Oncology, Drug Development
In the league tables
Similar deals
- Sensei Biotherapeutics placement Feb 2026 · US$200m · Biotech
- Avenzo Therapeutics placement Jun 2026 · US$215m · Biotech
- Remix Therapeutics placement Jun 2026 · US$100m · Biotech
- Eikon Therapeutics IPO Feb 2026 · US$381m · Oncology
- Parabilis Medicines IPO Jun 2026 · US$670m · Biotech
Sources
- Aug 2026 Latham & Watkins Advises on BlossomHill Therapeutics’ Upsized US$150 Million IPO lw.com
- Aug 2026 Guggenheim Securities: Joint Bookrunner to BlossomHill Therapeutics on its Initial Public Offering guggenheimsecurities.com
- 7 Aug 2026 Final IPO prospectus (424B4), BlossomHill Therapeutics, Inc. sec.gov
- 10 Aug 2026 BlossomHill Therapeutics Announces Upsized $150 Million IPO cooley.com


